Is Peak Concentration Needed in Therapeutic Drug Monitoring of Vancomycin? A Pharmacokinetic-Pharmacodynamic Analysis in Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia

Publisher： Karger

E-ISSN： 1421-9794|58|4|308-312

ISSN： 0009-3157

Source： Chemotherapy, Vol.58, Iss.4, 2012-11, pp. : 308-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidemiology of Methicillin-Resistant Staphylococcus aureus

By  

Chemotherapy, Vol. 45, Iss. 2, 1999-03 ,pp. : 121-134

Karger

Access to resources Recommend Favorite

In vitro Activities of Nisin Alone or in Combination with Vancomycin and Ciprofloxacin against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains

By  

Chemotherapy, Vol. 57, Iss. 6, 2012-02 ,pp. : 511-516

Karger

Access to resources Recommend Favorite

Efficacy of Quinupristin-Dalfopristin against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Insensitive S. aureus in a Model of Hematogenous Pulmonary Infection

By  

Chemotherapy, Vol. 50, Iss. 5, 2004-11 ,pp. : 260-264

Karger

Access to resources Recommend Favorite

Direct Detection of Methicillin-Resistant Staphylococcus Aureus in Sputum Specimens from Patients with Hospital-Associated Pneumonia Using a Novel Multilocus Pcr Assay

By Huang Zeng-Guang   Zheng Xing-Zheng   Guan Jing   Xiao Shu-Nian   Zhuo Chao  

Pathogens, Vol. 4, Iss. 2, 2015-04 ,pp. : 199-209

MDPI

Access to resources Recommend Favorite

Evaluation of the Combined Effects of Stilbenoid from Shorea gibbosa and Vancomycin against Methicillin-Resistant Staphylococcus aureus (MRSA)

By Basri Dayang Fredalina   Luoi Chan Kin   Azmi Abdul Muin   Latip Jalifah  

Pharmaceuticals, Vol. 5, Iss. 9, 2012-09 ,pp. : 1032-1043

MDPI

Access to resources Recommend Favorite